BET proteins enhance the oncogenic functions of major cancer drivers by elevating the expression of these drivers, such as c-Myc in multiple myeloma, androgen receptor (AR) and ETS-related gene (ERG) in prostate cancer, and TWIST in breast cancer [127]. This evidence concerns the gene ERG and plasma cell myeloma.